Search

Author/Creator Powell, Steven F.

1. A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors. Issue 1 (4th December 2019)

Authors:
Cohen, Ezra E. W.; Pishvaian, Michael J.; Shepard, Dale R.; Wang, Ding; Weiss, Jared; Johnson, Melissa L.; Chung, Christine H.; Chen, Ying; Huang, Bo; Davis, Craig B.; Toffalorio, Francesca; Thall, Aron; Powell, Steven F.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H. (April 2019)

Authors:
Gubens, Matthew A.; Sequist, Lecia V.; Stevenson, James P.; Powell, Steven F.; Villaruz, Liza C.; Gadgeel, Shirish M.; Langer, Corey J.; Patnaik, Amita; Borghaei, Hossein; Jalal, Shadia I.; Fiore, Joseph; Saraf, Sanatan; Raftopoulos, Harry; Gandhi, Leena
Journal:
Lung cancer
Issue:
Volume 130(2019)
Page Start:
59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search